CIK 0001314102
- Non-accelerated filer
- Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262774444
- Phone
- +1 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-09 | Paggiarino Dario A. Chief Medical Officer | Grant or award · Restricted Stock Units | +17,500 | 17,500 | ||
| 2022-02-09 | Paggiarino Dario A. Chief Medical Officer | Option exercise · Restricted Stock Units | −4,966 | 9,934 | ||
| 2022-02-09 | Paggiarino Dario A. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2022-02-09 | Jones David Scott SVP & Chief Commercial Officer | Option exercise | +4,966 | 14,097 | ||
| 2022-02-09 | Jones David Scott SVP & Chief Commercial Officer | Shares withheld for taxes | −1,473 | $10.13 | $15K | 12,624 |
| 2022-02-09 | Jones David Scott SVP & Chief Commercial Officer | Grant or award · Restricted Stock Units | +15,000 | 15,000 | ||
| 2022-02-09 | Jones David Scott SVP & Chief Commercial Officer | Option exercise · Restricted Stock Units | −4,966 | 9,934 | ||
| 2022-02-09 | Jones David Scott SVP & Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2022-02-09 | Lurker Nancy President & CEO | Option exercise | +17,533 | 124,098 | ||
| 2022-02-09 | Lurker Nancy President & CEO | Option exercise · Restricted Stock Units | −17,533 | 35,067 | ||
| 2022-02-09 | Lurker Nancy President & CEO | Grant or award · Restricted Stock Units | +60,000 | 60,000 | ||
| 2022-02-09 | Lurker Nancy President & CEO | Grant or award · Stock Option (Right to Buy) | +240,000 | 240,000 | ||
| 2022-01-10 | Pine Michael Craig Chief Corp Dev.&Strat. Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2021-11-15 | Lurker Nancy President & CEO | Sale | −10,000 | $20.15 | $201K | 103,546 |
| 2021-11-01 | Duker Jay S. Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +239,700 | 239,700 | ||
| 2021-11-01 | Jones David Scott SVP & Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-11-01 | Duker Jay S. Chief Operating Officer | Grant or award · Restricted Stock Units | +15,258 | 15,258 | ||
| 2021-11-01 | Duker Jay S. Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +305,000 | 305,000 | ||
| 2021-06-22 | Godshall Douglas Evan Director | Option exercise | +2,500 | 8,016 | ||
| 2021-06-22 | Godshall Douglas Evan Director | Option exercise · Restricted Stock Units | +2,500 | 0 |
Page 29 of 31 · 616 trades